488 related articles for article (PubMed ID: 2687875)
1. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.
Kraus MH; Issing W; Miki T; Popescu NC; Aaronson SA
Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9193-7. PubMed ID: 2687875
[TBL] [Abstract][Full Text] [Related]
2. c-erbB3 gene encodes secreted as well as transmembrane receptor tyrosine kinase.
Katoh M; Yazaki Y; Sugimura T; Terada M
Biochem Biophys Res Commun; 1993 May; 192(3):1189-97. PubMed ID: 7685162
[TBL] [Abstract][Full Text] [Related]
3. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.
Semba K; Kamata N; Toyoshima K; Yamamoto T
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6497-501. PubMed ID: 2995967
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues.
Lee H; Maihle NJ
Oncogene; 1998 Jun; 16(25):3243-52. PubMed ID: 9681822
[TBL] [Abstract][Full Text] [Related]
5. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.
Alimandi M; Romano A; Curia MC; Muraro R; Fedi P; Aaronson SA; Di Fiore PP; Kraus MH
Oncogene; 1995 May; 10(9):1813-21. PubMed ID: 7538656
[TBL] [Abstract][Full Text] [Related]
6. Amplification of a novel v-erbB-related gene in a human mammary carcinoma.
King CR; Kraus MH; Aaronson SA
Science; 1985 Sep; 229(4717):974-6. PubMed ID: 2992089
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells.
Kraus MH; Fedi P; Starks V; Muraro R; Aaronson SA
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2900-4. PubMed ID: 8464905
[TBL] [Abstract][Full Text] [Related]
8. erbB-3, a third member of the erbB/epidermal growth factor receptor gene family: its expression in head and neck cancer cell lines.
Issing WJ; Heppt WJ; Kastenbauer ER
Eur Arch Otorhinolaryngol; 1993; 250(7):392-5. PubMed ID: 8286103
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia.
Di Fiore PP; Kraus MH
Cancer Treat Res; 1992; 61():139-60. PubMed ID: 1360229
[No Abstract] [Full Text] [Related]
10. Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2.
Maurer CA; Friess H; Kretschmann B; Zimmermann A; Stauffer A; Baer HU; Korc M; Büchler MW
Hum Pathol; 1998 Aug; 29(8):771-7. PubMed ID: 9712416
[TBL] [Abstract][Full Text] [Related]
11. Cloning, expression, and biological effects of erbB-2/neu gene in mammalian cells.
Di Fiore PP; Segatto O; Aaronson SA
Methods Enzymol; 1991; 198():272-7. PubMed ID: 1677443
[No Abstract] [Full Text] [Related]
12. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene.
Plowman GD; Whitney GS; Neubauer MG; Green JM; McDonald VL; Todaro GJ; Shoyab M
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):4905-9. PubMed ID: 2164210
[TBL] [Abstract][Full Text] [Related]
13. The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases.
Kruh GD; Perego R; Miki T; Aaronson SA
Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5802-6. PubMed ID: 2198571
[TBL] [Abstract][Full Text] [Related]
14. Cloning of the rat ErbB3 cDNA and characterization of the recombinant protein.
Hellyer NJ; Kim HH; Greaves CH; Sierke SL; Koland JG
Gene; 1995 Nov; 165(2):279-84. PubMed ID: 8522190
[TBL] [Abstract][Full Text] [Related]
15. Altered gene expression in drug-resistant human breast cancer cells.
Wosikowski K; Schuurhuis D; Kops GJ; Saceda M; Bates SE
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2405-14. PubMed ID: 9815641
[TBL] [Abstract][Full Text] [Related]
16. Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing.
Rodrigues GA; Naujokas MA; Park M
Mol Cell Biol; 1991 Jun; 11(6):2962-70. PubMed ID: 1710022
[TBL] [Abstract][Full Text] [Related]
17. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.
Yarden Y; Kuang WJ; Yang-Feng T; Coussens L; Munemitsu S; Dull TJ; Chen E; Schlessinger J; Francke U; Ullrich A
EMBO J; 1987 Nov; 6(11):3341-51. PubMed ID: 2448137
[TBL] [Abstract][Full Text] [Related]
18. The epidermal growth factor receptor and its ligands.
Wells A
Cancer Treat Res; 1989; 47():143-68. PubMed ID: 2576995
[No Abstract] [Full Text] [Related]
19. EGF receptor inhibitors increase ErbB3 mRNA and protein levels in breast cancer cells.
Grøvdal LM; Kim J; Holst MR; Knudsen SL; Grandal MV; van Deurs B
Cell Signal; 2012 Jan; 24(1):296-301. PubMed ID: 21951604
[TBL] [Abstract][Full Text] [Related]
20. Deletion-mutant epidermal growth factor receptor in human gliomas: effects of type II mutation on receptor function.
Humphrey PA; Gangarosa LM; Wong AJ; Archer GE; Lund-Johansen M; Bjerkvig R; Laerum OD; Friedman HS; Bigner DD
Biochem Biophys Res Commun; 1991 Aug; 178(3):1413-20. PubMed ID: 1678600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
